Quang X. Pham, CEO and Chairman, 10% Owner at Cadrenal Therapeutics, Inc. (CVKD), sold 1,300 shares at $14.01 ($18K) on 2025-10-01, disclosed to the SEC on 2025-10-01.
Scheduled sale ($18k) by CEO and Chairman, 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.01 | 419 | $6K | 32.2% |
| 2 | $14.01 | 881 | $12K | 67.8% |
| Total | $14.01 avg | 1,300 | $18K | 100% |
| Filing → |
| CVKD | SELL | 2026-06-24 | $40K | — | Filing → |
| CVKD | SELL | 2026-06-18 | $13K | — | Filing → |
| CVKD | SELL | 2026-06-15 | $70K | — | Filing → |